3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
11
Prostatic Neoplasms
6
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Liver Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Liver Cirrhosis
2
Kidney Neoplasms
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Urologic Neoplasms
1
Urethral Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Solid Tumor
1
Renal Colic
1
Rectal Neoplasms
1
Pregnancy, Ectopic
1
Pneumonia
1
Pleural Effusion
1
Phlebitis
1
Penile Neoplasms
1
Mesothelioma
1
Melanoma
1
Margins of Excision
1
Lymphoma, Primary Effusion
1
Interventions
Propranolol
7
Timolol
6
Lasers, Dye
3
Population Groups
2
Nadolol
2
Imiquimod
2
Atenolol
2
propranolol mustard
1
Ultrasonography
1
Surgery, Computer-Assisted
1
Ophthalmic Solutions
1
Ointments
1
Mupirocin
1
Lasers, Solid-State
1
Lasers
1
Captopril
1
Bleomycin
1
Adrenergic beta-Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hemangioma, Capillary
×
Ultrasonography
×
Clear all
NCT05484245
2025-05-16
SOMALI
Sklifosovsky Institute of Emergency Care
Phase NA
Recruiting
100 enrolled